Bill Pruitt is the Managing Director and co-founder of Ocean Azul Partners. See portfolio, sector focus and contact routes.
Bill Pruitt is the Managing Director and co-founder of Ocean Azul Partners, an early-stage venture capital firm in Miami, Florida, after retiring as Managing Partner for Arthur Andersen’s Florida, Caribbean, and Venezuela regions following 33 years there[1][4]. His investment thesis targets early-stage B2B software and deep tech companies leveraging applied AI, robotics, or connectivity, with a geographic focus on the United States and Israel[1][3]. While specific check sizes and lead/follow behavior are not publicly detailed, Pruitt is recognized as an active investor and independent board director who has guided companies to major exits[1]. Notable portfolio companies include KOS Pharmaceuticals, acquired by Abbott for over $2 billion; MAKO Surgical, acquired by Stryker; and Virtustream, acquired by Dell EMC[1]. He currently serves on the boards of itopia, Inc., Swift Sync, Inc., and NV5 Global, Inc., reflecting his ongoing engagement with high-growth tech firms[2][4]. Pruitt has no widely published public writing or distinctive point of view documented in available sources beyond his board roles and investment track record[1][2].
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Miami when building a target list.
Investors like Bill Pruitt · Full investor directory · Investor access · Company funding database